|
Mikhailova Z.D., Omarova Yu.V.
Kidney damage in patients with CHF and obesity (local register data)
|
№3 / 2022
|
|
C.P. Kovesdy, S. Furth, C. Zoccali
Obesity and kidney disease: hidden consequences of the epidemic
|
№1 / 2017
|
|
N.A. Mihajlova, S.V. Tishkina
Features in managing patients with chronic kidney disease and type 2 diabetes: the need for a multidisciplinary approach
|
№2 / 2016
|
|
Ja.F. Zverev, V.M. Brjuhanov
Modern view on mechanisms of uric acid nephrolithiasis
|
№5-6 / 2015
|
|
N.A. Konyshko, T.E. Morozova.
Biometric predictors of kidney remodeling in pregnant women
|
№5 / 2014
|
|
S.S. Nagaitseva, M.Yu. Shvetsov, A.N Gerasimov, Yu.D Shalyagin, E.S. Ivanova, E.M. Shilov
Use of survey in chronic kidney disease stratification
|
№1 / 2014
|
|
S.A. Savelieva, A.A. Kriachkova, I.M. Kutyrina, M.V. Shestakova
Cardio-renal interrelations in patients with diabetes mellitus type 2 and obesity
|
№5 / 2011
|
|
M.G. Gallyamov, M.M. Severova, O.A. Surkova
Development of early stages of chronic kidney disease in patients with obesity
|
№6 / 2010
|
|
S.A. Savelyeva, A.A. Kryachkova, A.V. Zhelezniakova, O.K. Vikulova, I.M. Kutyrina, M.V. Shestakova
Influence of obesity on kidney disease in patients with diabetes mellitus type 2
|
№6 / 2010
|
|
E.A. Saginova, A.D. Aksiutin, T.N. Krasnova, V.V. Fomin, N.A. Moukhin
Peculiarities of IgA-nephropathy clinical course, associated with excess body mass weight
|
№5 / 2010
|
|
V.V. Fomin, E.A. Saginova
Aliskiren – direct renin inhibitor in treatment of cardio-renal syndrome in patients with metabolic syndrome and obesity
|
№4 / 2010
|
|
I.M. Kutyrina, A.A. Kriachkova, S.A. Savelieva, M.V. Shestakova
Role of aldosterone in development of kidney disease in metabolic syndrome, associated with obesity
|
№4 / 2010
|
Русский
